ctrl K

Price Alert

bioAffinity Technologies ... (BIAF)

NASDAQ: BIAF · Real-Time Price · USD

2.61

-0.17 (-6.12%)

At close: Oct 03, 2025, 3:59 PM

2.82

1.44%

Pre-market: Oct 03, 2025, 09:29 AM EDT

bioAffinity Revenue Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Sep 30, 2023
Health Care, Patient Service Revenue	2.51M	169K	23.92K	23.92K	427	248.65K
Health Care, Patient Service Revenue Growth	+1386.66%	+606.55%	0.00%	+5501.64%	-99.83%	n/a
Other Revenues Revenue	4.38K	n/a	n/a	n/a	n/a	n/a
Other Revenues Revenue Growth	n/a	n/a	n/a	n/a	n/a	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Selling, General, and Administrative Revenue	2.21M	2.45M	2.92M	2.37M	2.47M	2.19M	2.21M	2.02M	1.4M	1.15M	1.19M	596.48K	349.41K	352.52K	289.62K	161.55K	242.62K	186.99K	391.18K
Selling, General, and Administrative Revenue Growth	-9.72%	-15.99%	+23.47%	-4.37%	+13.13%	-1.26%	+9.39%	+44.06%	+22.39%	-3.17%	+98.75%	+70.71%	-0.88%	+21.72%	+79.28%	-33.41%	+29.75%	-52.20%	n/a
Research and Development Revenue	440.65K	367.39K	518.19K	368.2K	402.43K	442.6K	528.17K	330.38K	370.38K	389.25K	197.25K	380.69K	335.87K	332.35K	370.13K	364.74K	286.95K	304.22K	410.54K
Research and Development Revenue Growth	+19.94%	-29.10%	+40.73%	-8.51%	-9.08%	-16.20%	+59.87%	-10.80%	-4.85%	+97.33%	-48.19%	+13.34%	+1.06%	-10.21%	+1.48%	+27.11%	-5.68%	-25.90%	n/a

Ask AI